SAN

75.67

+0.12%↑

ARGX

757.6

-0.21%↓

SHL.DE

34.6

-1.2%↓

PHIA

22.5

-0.92%↓

FRE

37.32

-0.85%↓

SAN

75.67

+0.12%↑

ARGX

757.6

-0.21%↓

SHL.DE

34.6

-1.2%↓

PHIA

22.5

-0.92%↓

FRE

37.32

-0.85%↓

SAN

75.67

+0.12%↑

ARGX

757.6

-0.21%↓

SHL.DE

34.6

-1.2%↓

PHIA

22.5

-0.92%↓

FRE

37.32

-0.85%↓

SAN

75.67

+0.12%↑

ARGX

757.6

-0.21%↓

SHL.DE

34.6

-1.2%↓

PHIA

22.5

-0.92%↓

FRE

37.32

-0.85%↓

SAN

75.67

+0.12%↑

ARGX

757.6

-0.21%↓

SHL.DE

34.6

-1.2%↓

PHIA

22.5

-0.92%↓

FRE

37.32

-0.85%↓

Search

Vetoquinol SA

Open

SectorHealthcare

70.3

Overview

Share price change

24h

Current

Min

69.4

Max

70.8

Key metrics

By Trading Economics

Income

7.2M

32M

Sales

10M

268M

P/E

Sector Avg

14.312

49.052

Dividend yield

1.34

Profit margin

12.043

Employees

2,422

EBITDA

252M

301M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+56.92% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.34%

2.36%

Next Earnings

11 wrz 2026

Market Stats

By TradingEconomics

Market Cap

-113M

822M

Previous open

70.3

Previous close

70.3

News Sentiment

By Acuity

50%

50%

154 / 344 Ranking in Healthcare

Vetoquinol SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

10 cze 2026, 23:36 UTC

Earnings

Correction to Oracle Reports Higher 4Q Profit Article

10 cze 2026, 23:19 UTC

Hot Stocks

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

10 cze 2026, 23:09 UTC

Major Market Movers

PureCycle Technologies Slides on Offerings of Stock and Convertible Notes

10 cze 2026, 23:04 UTC

Earnings

Oracle Reports Higher 4Q Profit on Surging Cloud Revenue -- Update

10 cze 2026, 20:44 UTC

Major Market Movers

Caterpillar Raises Quarterly Dividend 8%

10 cze 2026, 23:49 UTC

Acquisitions, Mergers, Takeovers

Elliott: Northern Star Should Take No Options Off The Table

10 cze 2026, 23:48 UTC

Acquisitions, Mergers, Takeovers

Elliott: Reiterates Call For Formal Strategic Review of Northern Star

10 cze 2026, 23:48 UTC

Acquisitions, Mergers, Takeovers

Elliott: Northern Star Board Must Be Substantially Strengthened Beyond 1 Additional Director

10 cze 2026, 23:47 UTC

Market Talk

Nintendo's Stock Recovery Likely Deferred Without Mario Game -- Market Talk

10 cze 2026, 23:47 UTC

Acquisitions, Mergers, Takeovers

Elliott: Board Letter Indicates It Doesn't Understand Magnitude of Change Required

10 cze 2026, 23:46 UTC

Acquisitions, Mergers, Takeovers

Elliott Investment Management: Northern Star Letter Validates Investment Thesis

10 cze 2026, 23:38 UTC

Market Talk

Global Equities Roundup: Market Talk

10 cze 2026, 23:38 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10 cze 2026, 23:38 UTC

Market Talk

Nikkei Likely to Fall on Renewed Concerns About Iran Conflict -- Market Talk

10 cze 2026, 23:32 UTC

Market Talk

Oil Rises Amid Escalating Supply-Disruption Fears -- Market Talk

10 cze 2026, 23:20 UTC

Market Talk

Wesfarmers's Bunnings Business Looks Resilient to Macro Headwinds -- Market Talk

10 cze 2026, 22:05 UTC

Market Talk

Correction to Bank of Canada Stays on Hold Market Talk

10 cze 2026, 21:57 UTC

Earnings

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 cze 2026, 21:52 UTC

Earnings

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 cze 2026, 21:35 UTC

Earnings

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 cze 2026, 21:22 UTC

Earnings

Oracle Stock Slides on Increased Capital Spending -- WSJ

10 cze 2026, 20:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

10 cze 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

10 cze 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 cze 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 cze 2026, 20:39 UTC

Market Talk
Earnings

Oracle Needs to Raise Less Capital to Fund Data-Center Buildout -- Market Talk

10 cze 2026, 20:34 UTC

Earnings

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 cze 2026, 20:33 UTC

Earnings

This 'Amazon for Travel' Firm Beat Earnings Expectations. The Stock Is Soaring. -- Barrons.com

10 cze 2026, 20:33 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

10 cze 2026, 20:33 UTC

Market Talk
Earnings

Oracle Health Expected to Grow Double-Digits This Fiscal Year -- Market Talk

Peer Comparison

Price change

Vetoquinol SA Forecast

Price Target

By TipRanks

56.92% upside

12 Months Forecast

Average 110 EUR  56.92%

High 110 EUR

Low 110 EUR

Based on 1 Wall Street analysts offering 12 month price targets forVetoquinol SA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Sentiment

By Acuity

154 / 344 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
help-icon Live chat